These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 23013600)

  • 41. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.
    Clase CM; Gao P; Tobe SW; McQueen MJ; Grosshennig A; Teo KK; Yusuf S; Mann JF;
    Ann Intern Med; 2011 Mar; 154(5):310-8. PubMed ID: 21357908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
    Skupien J; Smiles AM; Valo E; Ahluwalia TS; Gyorgy B; Sandholm N; Croall S; Lajer M; McDonnell K; Forsblom C; Harjutsalo V; Marre M; Galecki AT; Tregouet DA; Wu CY; Mychaleckyj JC; Nickerson H; Pragnell M; Rich SS; Pezzolesi MG; Hadjadj S; Rossing P; Groop PH; Krolewski AS
    Diabetes Care; 2019 Jan; 42(1):93-101. PubMed ID: 30455333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining GFR and albuminuria to classify CKD improves prediction of ESRD.
    Hallan SI; Ritz E; Lydersen S; Romundstad S; Kvenild K; Orth SR
    J Am Soc Nephrol; 2009 May; 20(5):1069-77. PubMed ID: 19357254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study.
    Fenton A; Chinnadurai R; Gullapudi L; Kampanis P; Dasgupta I; Ritchie J; Harding S; Ferro CJ; Kalra PA; Taal MW; Cockwell P
    PLoS Med; 2020 Feb; 17(2):e1003050. PubMed ID: 32109242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy.
    Vaduganathan M; Pareek M; Kristensen AMD; Biering-Sørensen T; Byrne C; Almarzooq Z; Olesen TB; Olsen MH; Bhatt DL
    Eur J Heart Fail; 2021 Mar; 23(3):384-392. PubMed ID: 33448580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.
    Oshima M; Jun M; Ohkuma T; Toyama T; Wada T; Cooper ME; Hadjadj S; Hamet P; Harrap S; Mancia G; Marre M; Williams B; Chalmers J; Woodward M; Perkovic V;
    Diabetologia; 2019 Nov; 62(11):1988-1997. PubMed ID: 31302707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presence of albuminuria predicts left ventricular mass in patients with chronic systemic arterial hypertension.
    de Beus E; Meijs MF; Bots ML; Visseren FL; Blankestijn PJ;
    Eur J Clin Invest; 2015 Jun; 45(6):550-6. PubMed ID: 25786814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults.
    Garimella PS; Biggs ML; Katz R; Ix JH; Bennett MR; Devarajan P; Kestenbaum BR; Siscovick DS; Jensen MK; Shlipak MG; Chaves PH; Sarnak MJ
    Kidney Int; 2015 Nov; 88(5):1126-34. PubMed ID: 26154925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III).
    Shafi T; Matsushita K; Selvin E; Sang Y; Astor BC; Inker LA; Coresh J
    BMC Nephrol; 2012 Jun; 13():42. PubMed ID: 22702805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S; Hansen TW; Goetze JP; Rossing P
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease.
    Van Laecke S; Nagler EV; Verbeke F; Van Biesen W; Vanholder R
    Am J Med; 2013 Sep; 126(9):825-31. PubMed ID: 23891286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.
    Levey AS; Gansevoort RT; Coresh J; Inker LA; Heerspink HL; Grams ME; Greene T; Tighiouart H; Matsushita K; Ballew SH; Sang Y; Vonesh E; Ying J; Manley T; de Zeeuw D; Eckardt KU; Levin A; Perkovic V; Zhang L; Willis K
    Am J Kidney Dis; 2020 Jan; 75(1):84-104. PubMed ID: 31473020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relation between Kidney Length and Cardiovascular and Renal Risk in High-Risk Patients.
    van der Sande NGC; Visseren FLJ; van der Graaf Y; Nathoe HM; de Borst GJ; Leiner T; Blankestijn PJ;
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):921-928. PubMed ID: 28487344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between Kidney Dysfunction and Ischemic Stroke Outcomes: Albuminuria, but Not Estimated Glomerular Filtration Rate, Is Associated with the Risk of Further Vascular Events and Mortality after Stroke.
    Lee SJ; Lee DG
    PLoS One; 2016; 11(5):e0155939. PubMed ID: 27213281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The renoprotective effects of sodium-glucose cotransporter 2 inhibitors versus placebo in patients with type 2 diabetes with or without prevalent kidney disease: A systematic review and meta-analysis.
    Wang C; Zhou Y; Kong Z; Wang X; Lv W; Geng Z; Wang Y
    Diabetes Obes Metab; 2019 Apr; 21(4):1018-1026. PubMed ID: 30565382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.
    Kanda E; Usui T; Kashihara N; Iseki C; Iseki K; Nangaku M
    Clin Exp Nephrol; 2018 Apr; 22(2):318-327. PubMed ID: 28884361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Value of the Estimated Glomerular Filtration Rate Decline in Hypertensive Patients Without Chronic Kidney Disease.
    Coll-de-Tuero G; Comas-Cufí M; Rodríguez-Poncelas A; Barrot-de-la Puente J; Blanch J; Figa-Vaello J; Barceló MA; Saez M
    Am J Hypertens; 2019 Aug; 32(9):890-899. PubMed ID: 30794282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.